Delivering Knowledge Exchange at the Babraham Research Campus

Babraham Bioscience Technologies Ltd (BBT), the Institute’s wholly-owned trading arm, delivers the knowledge exchange remit and facilitates academic-commercial links. BBT actively manages the Institute’s intellectual property, negotiates commercial research partnerships and has established spin-out companies.

The translation of the Institute’s pioneering epigenetics research has resulted in several patent applications and licensing to companies, including an ongoing relationship with CellCentric Ltd. BBT also manages the campus Bioincubator, home to 28 early-stage bioventures, including a biopharmaceutical spin-out based on the Institute’s antibody expertise – Crescendo Biologics Ltd.